
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $353.7M | -- | -- | $3.34 | -- |
08/20/2025 | Q2 | $309.6M | -- | -- | $1.86 | -- |
05/07/2025 | Q1 | $257M | $304.1M | $1.38 | $1.42 | -$0.04 |
02/13/2025 | Q4 | $290.8M | $332.5M | $3.11 | $2.50 | $0.61 |
11/05/2024 | Q3 | $328.3M | $340.8M | $3.20 | $3.67 | -$0.47 |
08/20/2024 | Q2 | $307M | $342.2M | $3.30 | $2.84 | $0.47 |
05/14/2024 | Q1 | $280M | $318.6M | $2.38 | $2.01 | $0.37 |
02/13/2024 | Q4 | $322.6M | $327.3M | $4.30 | $2.62 | $1.68 |
11/02/2023 | Q3 | -- | -- | $2.91 | $2.81 | $0.10 |
08/23/2023 | Q2 | -- | -- | $3.65 | $2.88 | $0.77 |
05/23/2023 | Q1 | -- | -- | $3.22 | $1.71 | $1.51 |
02/21/2023 | Q4 | -- | -- | $3.84 | $4.25 | -$0.41 |
11/10/2022 | Q3 | -- | -- | $8.35 | $4.16 | $4.19 |
07/28/2022 | Q2 | -- | -- | $3.83 | $3.98 | -$0.15 |
05/10/2022 | Q1 | -- | -- | $2.78 | $3.49 | -$0.71 |
02/17/2022 | Q4 | -- | -- | $3.09 | $4.26 | -$1.17 |
11/10/2021 | Q3 | -- | -- | $5.97 | $4.15 | $1.83 |
07/27/2021 | Q2 | -- | -- | $4.31 | $2.94 | $1.37 |
04/29/2021 | Q1 | -- | -- | $11.69 | $1.73 | $9.96 |
03/24/2021 | Q4 | -- | -- | -$4.39 | $1.00 | -$5.39 |
11/05/2020 | Q3 | -- | -- | $0.63 | $0.58 | $0.05 |
07/29/2020 | Q2 | -- | -- | -$1.32 | -$0.46 | -$0.86 |
05/13/2020 | Q1 | -- | -- | -$0.97 | -$0.18 | -$0.79 |
02/10/2020 | Q4 | -- | -- | -$5.69 | $1.10 | -$6.79 |
10/31/2019 | Q3 | -- | -- | $1.54 | $1.06 | $0.48 |
07/31/2019 | Q2 | -- | -- | -$0.13 | -$0.06 | -$0.07 |
05/06/2019 | Q1 | -- | -- | -$0.15 | -$0.33 | $0.18 |
01/31/2019 | Q4 | -- | -- | $0.45 | $0.92 | -$0.47 |
11/13/2018 | Q3 | -- | -- | $1.35 | $0.64 | $0.71 |
08/01/2018 | Q2 | -- | -- | $0.78 | $0.57 | $0.21 |
05/08/2018 | Q1 | -- | -- | $0.45 | $0.29 | $0.16 |
02/05/2018 | Q4 | -- | -- | $1.05 | $0.60 | $0.45 |
11/14/2017 | Q3 | -- | -- | $0.60 | $0.23 | $0.37 |
07/27/2017 | Q2 | -- | -- | $0.45 | $0.16 | $0.29 |
05/22/2017 | Q1 | -- | -- | $0.00 | -$0.03 | $0.03 |
02/14/2017 | Q4 | -- | -- | $0.09 | $0.02 | $0.07 |
11/14/2016 | Q3 | -- | -- | $0.07 | $0.01 | $0.06 |
08/11/2016 | Q2 | -- | -- | -- | $0.05 | -- |
05/12/2016 | Q1 | -- | -- | -- | $0.07 | -- |
02/03/2016 | Q4 | -- | -- | $0.09 | $0.15 | -$0.06 |
10/27/2015 | Q3 | -- | -- | $0.13 | $0.16 | -$0.03 |
Navios Maritime Partners LP reported $304.1M worth of top line sales in its most recent quarter.
Navios Maritime Partners LP announced earnings per share of $1.38 which represents a miss of analyst forecast a $1.42 per share.
Navios Maritime Partners LP reported $100.6M that represents $3.40 per share over the last quarter.
Navios Maritime Partners LP's earnings are forecast to decrease from $11.98 per share to $11.17 per share next year representing a decrease of -23.75%.
Navios Maritime Partners LP's next earnings date is August 20, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.